Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin E, UDCA, and Pentoxifylline in Egyptian NASH Patients
NCT04977661Phase 4Completed
- Sponsor
- Kafrelsheikh University
- Start
- Feb 2020
- Primary completion
- May 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in Nonalcoholic steatohepatitis (NASH) comparing Vitamin E, UDCA and Pentoxifylline (3 arms). Primary endpoint: Resolution of Nonalcoholic Steatohepatitis at 3 months. Started Feb 2020; status: completed.
02
Drugs
vitamin eursodeoxycholic acidpentoxifylline
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT04977661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04977661.